Amir A. Jazaeri

The University of Texas MD Anderson Cancer Center

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Gene Expression Profiles Associated with Response to Chemotherapy in Epithelial Ovarian Cancers

(2023)10.1158/1078-0432.c.6518319

Top 100%

0DataRank

Top 100%0 citations

Christopher S. Awtrey, Gadisetti V.R. Chandramouli, Yao Eric Chuang, Javed Khan, Christos Sotiriou +7 more

Papers

Driven by 50 papers — median percentile 0. Top paper: “Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002)”.

Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002)

Gynecologic Oncology(2020)10.1016/j.ygyno.2019.12.034

N/A

5.8DataRank · unranked

155 citations

Wei Deng, Michael Frumovitz, Natália Buza, Stefania Bellone, Warner K. Huh +7 more

Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer

Cell Reports(2020)10.1016/j.celrep.2020.03.066

N/A

2.9DataRank · unranked

143 citations

Li Zhao, Christine Rojas, Nicholas W. Bateman, Hui Yao, Olivia D. Lara +41 more

Phase II study of pembrolizumab efficacy and safety in women with recurrent small cell neuroendocrine carcinoma of the lower genital tract

Gynecologic Oncology(2020)10.1016/j.ygyno.2020.05.682

N/A

2.3DataRank · unranked

71 citations

Shannon N. Westin, Gloria Salvo, Abdulrazzak Zarifa, Mingxuan Xu, Timothy A. Yap +6 more

Efficacy and safety of autologous tumor-infiltrating lymphocytes in recurrent or refractory ovarian cancer, colorectal cancer, and pancreatic ductal adenocarcinoma

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-006822

N/A

1.3DataRank · unranked

52 citations

Anne Knisely, David Vining, Scott Kopetz, Michael J. Overman, Milind Javle +16 more

The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trial

Investigational New Drugs(2021)10.1007/s10637-020-01043-9

N/A

1.1DataRank · unranked

25 citations

Amir A. Jazaeri, Shannon N. Westin, Anil K. Sood, Lois M. Ramondetta, Mingxuan Xu +8 more

Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer: Clinical and translational results from a phase 2 trial

Med(2024)10.1016/j.medj.2024.07.022

N/A

0.299DataRank · unranked

4 citations

Minghao Dang, Sanghoon Lee, Bryan Fellman, Shannon N. Westin, Anil K. Sood +19 more

METI: Deep profiling of tumor ecosystems by integrating cell morphology and spatial transcriptomics

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.10.06.561287

N/A

0.165DataRank · unranked

2 citations

Yunhe Liu, Jiang‐Jiang Qin, Jingjing Wu, Jianfeng Chen, Melissa Pool Pizzi +24 more

Pembrolizumab in vaginal and vulvar squamous cell carcinoma: a case series from a phase II basket trial

Scientific Reports(2021)10.1038/s41598-021-83317-7

N/A

0DataRank · unranked

35 citations

Amir A. Jazaeri, Pamela T. Soliman, Nicole D. Fleming, Jing Gong, Sarina A. Piha‐Paul +4 more

Applications of CRISPR Genome Editing to Advance the Next Generation of Adoptive Cell Therapies for Cancer

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1083

N/A

0DataRank · unranked

23 citations

Amir A. Jazaeri, Patrick Hwu, Samantha M. Fix

Candidate HPV-Specific T-Cells Expand in the Tumor Microenvironment During Chemoradiotherapy

Research Square(2021)10.21203/rs.3.rs-105933/v1

N/A

0DataRank · unranked

0 citations

Molly B. El Alam, Erica J. Lynn, Julianna K. Edwards, Tatiana V. Karpinets, Xiaogang Wu +39 more

Selinexor in combination with weekly paclitaxel in patients with advanced or metastatic solid tumors: Results of an open label, single-center, multiarm phase 1b study.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.5565

N/A

0DataRank · unranked

0 citations

Siqing Fu, Apostolia M. Tsimberidou, Sarina A. Piha‐Paul, Fechukwu Akhmedzhanov, Bülent Yılmaz +15 more

CRISPR-mediated TGFBR2 knockout renders human ovarian cancer tumor-infiltrating lymphocytes resistant to TGF-β signaling

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2021-003750

N/A

0DataRank · unranked

44 citations

Marie‐Andrée Forget, Donastas Sakellariou-Thompson, Yunfei Wang, Tamara Griffiths, Minjung Lee +10 more

Adoptive cell therapy in gynecologic cancers: A systematic review and meta-analysis

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.03.013

N/A

0DataRank · unranked

20 citations

Goldy C. George, Mirella Nardo, Kate J. Krause, Amir A. Jazaeri, Amadeo B. Biter +2 more

Contemporary primary treatment of women with stage II-IV low-grade serous ovarian/peritoneal cancer (LGSOC): Determinants of relapse and disease-free survival

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.09.005

N/A

0DataRank · unranked

16 citations

Lauren Cobb, Shannon N. Westin, Yingao Zhang, Amir A. Jazaeri, Anaís Malpica +2 more

Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16+ Cancers

Cancer Immunology Research(2022)10.1158/2326-6066.cir-21-0119

N/A

0DataRank · unranked

14 citations

Molly B. El, Erica J. Lynn, Julianna Bronk, Tatiana V. Karpinets, Xiaogang Wu +40 more

Gynecologic tract melanoma in the contemporary therapeutic era: High rates of local and distant disease progression

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.09.026

N/A

0DataRank · unranked

13 citations

Morgan A. Farr, Priyadharsini Nagarajan, Joel Ho, Andrew J. Bishop, Anuja Jhingran +7 more

Selinexor in combination with weekly paclitaxel in patients with metastatic solid tumors: Results of an open label, single-center, multi-arm phase 1b study with expansion phase in ovarian cancer

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.11.004

N/A

0DataRank · unranked

8 citations

Siqing Fu, Apostolia M. Tsimberidou, Sarina A. Piha‐Paul, Fechukwu Akhmedzhanov, Bülent Yılmaz +16 more

Hormone receptor status and the role of oophorectomy in uterine leiomyosarcoma

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.09.024

N/A

0DataRank · unranked

5 citations

Jennifer Rumpf, Ravin Ratan, Nicole D. Fleming, Amir A. Jazaeri, Bryan Fellman +3 more

Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance

Nature Medicine(2023)10.1038/s41591-023-02371-y

N/A

0DataRank · unranked

493 citations

Enyu Dai, Yating Li, Guangchun Han, Guangsheng Pei, Davis R. Ingram +39 more

Phase II Trial of MEDI0457 and Durvalumab for Patients With Recurrent/Metastatic Human Papillomavirus-Associated Cancers

The Oncologist(2023)10.1093/oncolo/oyad085

N/A

0DataRank · unranked

28 citations

Amir A. Jazaeri, Shannon N. Westin, Curtis A. Pettaway, Solly George, Ryan Huey +8 more

Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum‐resistant ovarian cancer

Cancer(2023)10.1002/cncr.35126

N/A

0DataRank · unranked

18 citations

Anne Knisely, Naomi Adjei, Bryan Fellman, Ying Yuan, Ami Patel +16 more

Phase 1/2 trial of avelumab combined with utomilumab (4‐1BB agonist), PF‐04518600 (OX40 agonist), or radiotherapy in patients with advanced gynecologic malignancies

Cancer(2023)10.1002/cncr.35063

N/A

0DataRank · unranked

17 citations

Jibran Ahmed, Bettzy Stephen, Sarina A. Piha‐Paul, Daniel D. Karp, Abdulrazzak Zarifa +13 more

Clinical implications of tumor‐based next‐generation sequencing in high‐grade epithelial ovarian cancer

Cancer(2023)10.1002/cncr.34724

N/A

0DataRank · unranked

9 citations

Kenna Shaw, Fengyi Jin, Shannon N. Westin, Timothy A. Yap, Deanna Glassman +9 more

Predictors of Oncologic Outcome in Patients Receiving Phase I Investigational Therapy for Recurrent or Metastatic Cervical Cancer

Journal of Immunotherapy and Precision Oncology(2023)10.36401/jipo-22-23

N/A

0DataRank · unranked

1 citations

Heather Lin, Siqing Fu, Amadeo B. Biter, Ecaterina E. Dumbrava, Daniel D. Karp +15 more

Data from Gene Expression Profiles Associated with Response to Chemotherapy in Epithelial Ovarian Cancers

(2023)10.1158/1078-0432.c.6518319

Top 100%

0DataRank

Top 100%0 citations

Christopher S. Awtrey, Gadisetti V.R. Chandramouli, Yao Eric Chuang, Javed Khan, Christos Sotiriou +7 more

Data from Gene Expression Profiles Associated with Response to Chemotherapy in Epithelial Ovarian Cancers

(2023)10.1158/1078-0432.c.6518319.v1

Top 100%

0DataRank

Top 100%0 citations

Christopher S. Awtrey, Gadisetti V.R. Chandramouli, Yao Eric Chuang, Javed Khan, Christos Sotiriou +7 more

Data from Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16+ Cancers

(2023)10.1158/2326-6066.c.6550526

N/A

0DataRank · unranked

0 citations

Molly B. El, Erica J. Lynn, Julianna Bronk, Tatiana V. Karpinets, Xiaogang Wu +40 more

Supplemental Tables from Expansion of Candidate HPV-Specific T Cells in the Tumor Microenvironment during Chemoradiotherapy Is Prognostic in HPV16+ Cancers

INDIGO (University of Illinois at Chicago)(2023)10.1158/2326-6066.22544087.v1

Top 100%

0DataRank

Top 100%0 citations

Molly B. El, Erica J. Lynn, Julianna Bronk, Tatiana V. Karpinets, Xiaogang Wu +40 more

Translating biological insights into improved management of endometrial cancer

Nature Reviews Clinical Oncology(2024)10.1038/s41571-024-00934-7

N/A

0DataRank · unranked

32 citations

Amir A. Jazaeri, Shannon N. Westin, Barrett C. Lawson, Ann H. Klopp, Pamela T. Soliman +2 more

METI: deep profiling of tumor ecosystems by integrating cell morphology and spatial transcriptomics

Nature Communications(2024)10.1038/s41467-024-51708-9

N/A

0DataRank · unranked

22 citations

Yunhe Liu, Jiang‐Jiang Qin, Jianfeng Chen, Jingjing Wu, Melissa Pool Pizzi +25 more

Clinical and Genomic Landscape of RAS Mutations in Gynecologic Cancers

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-23-2819

N/A

0DataRank · unranked

12 citations

Yingao Zhang, Heather Lin, Oriol Mirallas, Pablo Álvarez Ballesteros, Mirella Nardo +19 more

Phase 1b study of batiraxcept in combination with durvalumab in patients with platinum-resistant ovarian cancer

iScience(2024)10.1016/j.isci.2024.109801

N/A

0DataRank · unranked

5 citations

Emily Hinchcliff, Elisabeth Gardiner, Reshma Rangwala, Kathryn Lito, Bryan Fellman +6 more

EGFR, HLA-G, CD70, c-MET, and NY-ESO1 as potential biomarkers in high grade epithelial ovarian carcinoma

Cancer Biomarkers(2024)10.3233/cbm-230200

N/A

0DataRank · unranked

5 citations

Anil K. Sood, Katy Rezvani, Amir A. Jazaeri, Jinsong Liu, Duc Vo

A colostomy for large bowel obstruction at the end of life: What do patients gain from palliative surgery?

Gynecologic Oncology(2024)10.1016/j.ygyno.2024.06.023

N/A

0DataRank · unranked

2 citations

Maria D Iniesta, Bryan Fellman, Amir A. Jazaeri, Larissa A Meyer, Nicole D. Fleming +3 more

Phase I/II study of TROP2 CAR engineered IL15-transduced cord blood-derived NK cells delivered intraperitoneally for the management of platinum resistant ovarian cancer, mesonephric-like adenocarcinoma, and pancreatic cancer.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.tps5626

N/A

0DataRank · unranked

9 citations

Hind Rafei, Rafet Başar, Pinaki P. Banerjee, Zeyad Metwalli, Kathryn Lito +13 more

Feasibility of using the handheld MasSpec pen technology for intraoperative identification of ovarian cancer during tumor reductive surgery.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.5573

N/A

0DataRank · unranked

1 citations

Charles A. Wolfe, Michael F. Keating, Marta Sans, Kelly M. Rangel, Calvin Sunny +10 more

Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics

Cancer Cell(2025)10.1016/j.ccell.2025.03.004

N/A

0DataRank · unranked

185 citations

Ansam Sinjab, Jimin Min, Guangchun Han, Francesca Paradiso, Yuanyuan Zhang +25 more

PPP2R1A mutations portend improved survival after cancer immunotherapy

Nature(2025)10.1038/s41586-025-09203-8

N/A

0DataRank · unranked

29 citations

Anne Knisely, Mitsutake Yano, Minghao Dang, Emily Hinchcliff, Sanghoon Lee +36 more

A pioneering artificial intelligence tool to predict treatment outcomes in ovarian cancer via diagnostic laparoscopy

Scientific Reports(2025)10.1038/s41598-025-98434-w

N/A

0DataRank · unranked

9 citations

Yu‐Chun Hsu, Amma Asare, Kai Zhang, Deanna Glassman, Katelyn F. Handley +10 more

Mesonephric-like adenocarcinoma of the female genital tract: Pathologic diagnosis, clinical outcomes, and novel therapeutics

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.04.583

N/A

0DataRank · unranked

5 citations

Anne M. Mills, Brooke E. Howitt, Rachel N. Grisham, Elizabeth D. Euscher, Hyun Soo Kim +16 more

Selective Alanine Transporter Utilization Is a Therapeutic Vulnerability in ARID1A-Mutant Ovarian Cancer

Cancer Research(2025)10.1158/0008-5472.can-25-0654

N/A

0DataRank · unranked

3 citations

Liping Liao, Rafał Zieliński, Javier A. Gomez, Akshay V. Basi, Erin H. Seeley +22 more

EON: Phase II trial of etigilimab (MPH313) in combination with nivolumab in patients with recurrent platinum-resistant clear cell ovarian cancer.

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.5573

N/A

0DataRank · unranked

1 citations

Emily Hinchcliff, Shuqi Wang, Amir A. Jazaeri, Anil K. Sood, Bryan Fellman +14 more

First-In-Human Trial of Encapsulated Cell-Based Protein Producers for Localized IL-2 in Patients with High-Grade Serous Ovarian Carcinoma

medRxiv(2025)10.1101/2025.11.07.25339137

N/A

0DataRank · unranked

0 citations

Samira Aghlara-Fotovat, Jake Schladenhauffen, Jonathon DeBonis, Juan Carlos Amador-Molina, Amanda Nash +24 more

Photodynamic therapy: An alternative technique to cervical conization for cervical dysplasia

Med(2025)10.1016/j.medj.2025.100922

N/A

0DataRank · unranked

0 citations

Amir A. Jazaeri, Jeffrey How

Correlation of surgeon radiology assessment with laparoscopic disease site scoring in patients with advanced ovarian cancer

International Journal of Gynecological Cancer(2020)10.1136/ijgc-2020-001718

N/A

0DataRank · unranked

8 citations

Shannon N. Westin, Larissa A. Meyer, Aaron Shafer, Jose Alejandro Rauh‐Hain, Michaela Onstad +12 more

Adaptive changes in the gut microbiome during standard-of-care chemoradiotherapy for gynecologic cancers

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.04.10.036426

N/A

0DataRank · unranked

2 citations

Travis T. Sims, Ramez Kouzy, Greyson Biegert, Joseph Abi Jaoude, Tatiana V. Karpinets +17 more

Deep learning on image-omics data in identifying prognostic immune biomarkers for ovarian cancer

Research Square(2020)10.21203/rs.3.rs-67036/v1

N/A

0DataRank · unranked

2 citations

Sammy Ferri‐Borgogno, Jianting Sheng, Tsz-Lun Yeung, Jared K. Burks, Paola Cappello +7 more

Modification of Homologous Recombination Deficiency Score Threshold and Association with Long-Term Survival in Epithelial Ovarian Cancer

Cancers(2021)10.3390/cancers13050946

N/A

0DataRank · unranked

62 citations

Amir A. Jazaeri, Bryan Fellman, Molly S. Daniels, Suzanna Penn, Cara Solimeno +7 more

Toxicity and efficacy of the combination of pembrolizumab with recommended or reduced starting doses of lenvatinib for treatment of recurrent endometrial cancer

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.04.034

N/A

0DataRank · unranked

54 citations

Shrina Patel, Bryan Fellman, Karen H. Lu, Patrick Hwu, Lois M. Ramondetta +5 more

A prospective study of the adaptive changes in the gut microbiome during standard-of-care chemoradiotherapy for gynecologic cancers

PLoS ONE(2021)10.1371/journal.pone.0247905

N/A

0DataRank · unranked

38 citations

Travis T. Sims, Ramez Kouzy, Greyson Biegert, Joseph Abi Jaoude, Tatiana V. Karpinets +17 more

Amir A. Jazaeri

Indexed papers

Top data-sharing exemplar

Papers